Healthcare affordability continues to be a struggle for many in the U.S. While the country grapples with changing views on government-mandated health insurance, millions are still either uninsured or ...

The Department of Health and Human Services Office of Inspector General (OIG) has issued a long-awaited, favorable advisory opinion regarding certain single-donor rare disease state patient assistance ...

Please provide your email address to receive an email when new articles are posted on . The programs are designed to provide anti-VEGF treatment for patients who are uninsured or underinsured.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

On December 7, 2015, OIG posted a modification adding additional strictures to a prior favorable Advisory Opinion (No. 07-11) regarding a charity’s operation of a patient assistance program (PAP) to ...

In the rapidly evolving landscape of healthcare, Pharma Patient Assistance Programs (PAP) have been a lifeline for many patients seeking access to essential medications. These programs aim to help ...

Nonprofit Patient Assistance Programs (PAPs), administered by organizations like Accessia Health, have been integral to the healthcare system for decades. Until recently, PAPs have primarily provided ...

The Novo Nordisk Patient Assistance Program (PAP) is based on the company’s commitment to people living with diabetes. The PAP provides medication at no cost to those who qualify. Patients who are ...

Arcutis Cares provides ZORYVE™ (roflumilast) cream 0.3% at no cost for financially eligible individuals who are uninsured or have Medicaid or Medicare Part D prescription coverage and cannot afford ...

Do Patients and Oncologists Discuss the Cost of Cancer Treatment? An Observational Study of Clinical Interactions Between African American Patients and Their Oncologists Pharmaceutical manufacturers ...

The competing strategies of patient assistance programs and co-pay accumulator adjustment programs create confusion and administrative burden for clinicians and patients, potentially reducing ...